The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Drug Delivery Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Synopsis
The global Drug Delivery Devices market size was US$ 45510 million in 2024 and is forecast to a readjusted size of US$ 63320 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug delivery devices corresponding to the medicine taken ways, such as syringe, spray bottle and implantable drug delivery devices etc.
The top five global manufacturers of drug delivery equipment are Cipla, Baxter International, Nipro Corporation, Roche and Boehringer Ingelheim, with a combined market share of 29 per cent. North America, which has a well-established healthcare infrastructure and a large number of leading pharmaceutical and biopharmaceutical companies (around 80% of the world"s research and development in biopharmaceutical is conducted by US-based firms), is the largest market for drug delivery, about for 47% followed by Europe with 28%.
The global Drug Delivery Devices market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Cipla
Baxter International
Nipro Corporation
Roche
Boehringer Ingelheim
Allergan
3M
BD
Catalent
Valeant Pharmaceuticals
Bayer AG
Chiesi
Phillips-Medisize
Johnson & Johnson
Shandong Weigao
Pfizer
B.Braun
Novartis AG
Zhengkang
Gerresheimer
COVIDIEN Medtronic
Schott forma vitrum
Alkermes
Skyepharma
By Type: (Dominant Segment vs High-Margin Innovation)
Injection Type
Mucosal Type
Implanted Type
Others Type
By Application: (Core Demand Driver vs Emerging Opportunity)
Pharmaceutical Companies
Hospitals
Clinics
Other
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Cipla in Europe)
- Emerging Product Trends: Injection Type adoption vs. Mucosal Type premiumization
- Demand-Side Dynamics: Pharmaceutical Companies growth in China vs. Hospitals potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
Southeast Asia
Japan
China
India
Australia
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Drug Delivery Devices market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Mucosal Type in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Hospitals in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Drug Delivery Devices value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
The global Drug Delivery Devices market size was US$ 45510 million in 2024 and is forecast to a readjusted size of US$ 63320 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug delivery devices corresponding to the medicine taken ways, such as syringe, spray bottle and implantable drug delivery devices etc.
The top five global manufacturers of drug delivery equipment are Cipla, Baxter International, Nipro Corporation, Roche and Boehringer Ingelheim, with a combined market share of 29 per cent. North America, which has a well-established healthcare infrastructure and a large number of leading pharmaceutical and biopharmaceutical companies (around 80% of the world"s research and development in biopharmaceutical is conducted by US-based firms), is the largest market for drug delivery, about for 47% followed by Europe with 28%.
The global Drug Delivery Devices market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Cipla
Baxter International
Nipro Corporation
Roche
Boehringer Ingelheim
Allergan
3M
BD
Catalent
Valeant Pharmaceuticals
Bayer AG
Chiesi
Phillips-Medisize
Johnson & Johnson
Shandong Weigao
Pfizer
B.Braun
Novartis AG
Zhengkang
Gerresheimer
COVIDIEN Medtronic
Schott forma vitrum
Alkermes
Skyepharma
By Type: (Dominant Segment vs High-Margin Innovation)
Injection Type
Mucosal Type
Implanted Type
Others Type
By Application: (Core Demand Driver vs Emerging Opportunity)
Pharmaceutical Companies
Hospitals
Clinics
Other
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Cipla in Europe)
- Emerging Product Trends: Injection Type adoption vs. Mucosal Type premiumization
- Demand-Side Dynamics: Pharmaceutical Companies growth in China vs. Hospitals potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
Southeast Asia
Japan
China
India
Australia
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Drug Delivery Devices market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Mucosal Type in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Hospitals in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Drug Delivery Devices value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Index1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Injection Type
1.2.3 Mucosal Type
1.2.4 Implanted Type
1.2.5 Others Type
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Companies
1.3.3 Hospitals
1.3.4 Clinics
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Delivery Devices Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Drug Delivery Devices Revenue Market Share by Region (2020-2025)
2.4 Global Drug Delivery Devices Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Drug Delivery Devices Market Size and Prospective (2020-2031)
2.5.2 Europe Drug Delivery Devices Market Size and Prospective (2020-2031)
2.5.3 Southeast Asia Drug Delivery Devices Market Size and Prospective (2020-2031)
2.5.4 Japan Drug Delivery Devices Market Size and Prospective (2020-2031)
2.5.5 China Drug Delivery Devices Market Size and Prospective (2020-2031)
2.5.6 India Drug Delivery Devices Market Size and Prospective (2020-2031)
2.5.7 Australia Drug Delivery Devices Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Drug Delivery Devices Historic Market Size by Type (2020-2025)
3.2 Global Drug Delivery Devices Forecasted Market Size by Type (2026-2031)
3.3 Different Types Drug Delivery Devices Representative Players
4 Breakdown Data by Application
4.1 Global Drug Delivery Devices Historic Market Size by Application (2020-2025)
4.2 Global Drug Delivery Devices Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Drug Delivery Devices Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Drug Delivery Devices Players by Revenue (2020-2025)
5.1.2 Global Drug Delivery Devices Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Drug Delivery Devices Revenue
5.4 Global Drug Delivery Devices Market Concentration Analysis
5.4.1 Global Drug Delivery Devices Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Drug Delivery Devices Revenue in 2024
5.5 Global Key Players of Drug Delivery Devices Head office and Area Served
5.6 Global Key Players of Drug Delivery Devices, Product and Application
5.7 Global Key Players of Drug Delivery Devices, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Drug Delivery Devices Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Drug Delivery Devices Market Size by Type (2020-2025)
6.1.2.2 North America Drug Delivery Devices Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Drug Delivery Devices Market Size by Application (2020-2025)
6.1.3.2 North America Drug Delivery Devices Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Drug Delivery Devices Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Drug Delivery Devices Market Size by Type (2020-2025)
6.2.2.2 Europe Drug Delivery Devices Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Drug Delivery Devices Market Size by Application (2020-2025)
6.2.3.2 Europe Drug Delivery Devices Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 Southeast Asia Market: Players, Segments and Downstream
6.3.1 Southeast Asia Drug Delivery Devices Revenue by Company (2020-2025)
6.3.2 Southeast Asia Market Size by Type
6.3.2.1 Southeast Asia Drug Delivery Devices Market Size by Type (2020-2025)
6.3.2.2 Southeast Asia Drug Delivery Devices Market Share by Type (2020-2025)
6.3.3 Southeast Asia Market Size by Application
6.3.3.1 Southeast Asia Drug Delivery Devices Market Size by Application (2020-2025)
6.3.3.2 Southeast Asia Drug Delivery Devices Market Share by Application (2020-2025)
6.3.4 Southeast Asia Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Drug Delivery Devices Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Drug Delivery Devices Market Size by Type (2020-2025)
6.4.2.2 Japan Drug Delivery Devices Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Drug Delivery Devices Market Size by Application (2020-2025)
6.4.3.2 Japan Drug Delivery Devices Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 China Market: Players, Segments and Downstream
6.5.1 China Drug Delivery Devices Revenue by Company (2020-2025)
6.5.2 China Market Size by Type
6.5.2.1 China Drug Delivery Devices Market Size by Type (2020-2025)
6.5.2.2 China Drug Delivery Devices Market Share by Type (2020-2025)
6.5.3 China Market Size by Application
6.5.3.1 China Drug Delivery Devices Market Size by Application (2020-2025)
6.5.3.2 China Drug Delivery Devices Market Share by Application (2020-2025)
6.5.4 China Market Trend and Opportunities
6.6 India Market: Players, Segments and Downstream
6.6.1 India Drug Delivery Devices Revenue by Company (2020-2025)
6.6.2 India Market Size by Type
6.6.2.1 India Drug Delivery Devices Market Size by Type (2020-2025)
6.6.2.2 India Drug Delivery Devices Market Share by Type (2020-2025)
6.6.3 India Market Size by Application
6.6.3.1 India Drug Delivery Devices Market Size by Application (2020-2025)
6.6.3.2 India Drug Delivery Devices Market Share by Application (2020-2025)
6.6.4 India Market Trend and Opportunities
7 Key Players Profiles
7.1 Cipla
7.1.1 Cipla Company Details
7.1.2 Cipla Business Overview
7.1.3 Cipla Drug Delivery Devices Introduction
7.1.4 Cipla Revenue in Drug Delivery Devices Business (2020-2025)
7.1.5 Cipla Recent Development
7.2 Baxter International
7.2.1 Baxter International Company Details
7.2.2 Baxter International Business Overview
7.2.3 Baxter International Drug Delivery Devices Introduction
7.2.4 Baxter International Revenue in Drug Delivery Devices Business (2020-2025)
7.2.5 Baxter International Recent Development
7.3 Nipro Corporation
7.3.1 Nipro Corporation Company Details
7.3.2 Nipro Corporation Business Overview
7.3.3 Nipro Corporation Drug Delivery Devices Introduction
7.3.4 Nipro Corporation Revenue in Drug Delivery Devices Business (2020-2025)
7.3.5 Nipro Corporation Recent Development
7.4 Roche
7.4.1 Roche Company Details
7.4.2 Roche Business Overview
7.4.3 Roche Drug Delivery Devices Introduction
7.4.4 Roche Revenue in Drug Delivery Devices Business (2020-2025)
7.4.5 Roche Recent Development
7.5 Boehringer Ingelheim
7.5.1 Boehringer Ingelheim Company Details
7.5.2 Boehringer Ingelheim Business Overview
7.5.3 Boehringer Ingelheim Drug Delivery Devices Introduction
7.5.4 Boehringer Ingelheim Revenue in Drug Delivery Devices Business (2020-2025)
7.5.5 Boehringer Ingelheim Recent Development
7.6 Allergan
7.6.1 Allergan Company Details
7.6.2 Allergan Business Overview
7.6.3 Allergan Drug Delivery Devices Introduction
7.6.4 Allergan Revenue in Drug Delivery Devices Business (2020-2025)
7.6.5 Allergan Recent Development
7.7 3M
7.7.1 3M Company Details
7.7.2 3M Business Overview
7.7.3 3M Drug Delivery Devices Introduction
7.7.4 3M Revenue in Drug Delivery Devices Business (2020-2025)
7.7.5 3M Recent Development
7.8 BD
7.8.1 BD Company Details
7.8.2 BD Business Overview
7.8.3 BD Drug Delivery Devices Introduction
7.8.4 BD Revenue in Drug Delivery Devices Business (2020-2025)
7.8.5 BD Recent Development
7.9 Catalent
7.9.1 Catalent Company Details
7.9.2 Catalent Business Overview
7.9.3 Catalent Drug Delivery Devices Introduction
7.9.4 Catalent Revenue in Drug Delivery Devices Business (2020-2025)
7.9.5 Catalent Recent Development
7.10 Valeant Pharmaceuticals
7.10.1 Valeant Pharmaceuticals Company Details
7.10.2 Valeant Pharmaceuticals Business Overview
7.10.3 Valeant Pharmaceuticals Drug Delivery Devices Introduction
7.10.4 Valeant Pharmaceuticals Revenue in Drug Delivery Devices Business (2020-2025)
7.10.5 Valeant Pharmaceuticals Recent Development
7.11 Bayer AG
7.11.1 Bayer AG Company Details
7.11.2 Bayer AG Business Overview
7.11.3 Bayer AG Drug Delivery Devices Introduction
7.11.4 Bayer AG Revenue in Drug Delivery Devices Business (2020-2025)
7.11.5 Bayer AG Recent Development
7.12 Chiesi
7.12.1 Chiesi Company Details
7.12.2 Chiesi Business Overview
7.12.3 Chiesi Drug Delivery Devices Introduction
7.12.4 Chiesi Revenue in Drug Delivery Devices Business (2020-2025)
7.12.5 Chiesi Recent Development
7.13 Phillips-Medisize
7.13.1 Phillips-Medisize Company Details
7.13.2 Phillips-Medisize Business Overview
7.13.3 Phillips-Medisize Drug Delivery Devices Introduction
7.13.4 Phillips-Medisize Revenue in Drug Delivery Devices Business (2020-2025)
7.13.5 Phillips-Medisize Recent Development
7.14 Johnson & Johnson
7.14.1 Johnson & Johnson Company Details
7.14.2 Johnson & Johnson Business Overview
7.14.3 Johnson & Johnson Drug Delivery Devices Introduction
7.14.4 Johnson & Johnson Revenue in Drug Delivery Devices Business (2020-2025)
7.14.5 Johnson & Johnson Recent Development
7.15 Shandong Weigao
7.15.1 Shandong Weigao Company Details
7.15.2 Shandong Weigao Business Overview
7.15.3 Shandong Weigao Drug Delivery Devices Introduction
7.15.4 Shandong Weigao Revenue in Drug Delivery Devices Business (2020-2025)
7.15.5 Shandong Weigao Recent Development
7.16 Pfizer
7.16.1 Pfizer Company Details
7.16.2 Pfizer Business Overview
7.16.3 Pfizer Drug Delivery Devices Introduction
7.16.4 Pfizer Revenue in Drug Delivery Devices Business (2020-2025)
7.16.5 Pfizer Recent Development
7.17 B.Braun
7.17.1 B.Braun Company Details
7.17.2 B.Braun Business Overview
7.17.3 B.Braun Drug Delivery Devices Introduction
7.17.4 B.Braun Revenue in Drug Delivery Devices Business (2020-2025)
7.17.5 B.Braun Recent Development
7.18 Novartis AG
7.18.1 Novartis AG Company Details
7.18.2 Novartis AG Business Overview
7.18.3 Novartis AG Drug Delivery Devices Introduction
7.18.4 Novartis AG Revenue in Drug Delivery Devices Business (2020-2025)
7.18.5 Novartis AG Recent Development
7.19 Zhengkang
7.19.1 Zhengkang Company Details
7.19.2 Zhengkang Business Overview
7.19.3 Zhengkang Drug Delivery Devices Introduction
7.19.4 Zhengkang Revenue in Drug Delivery Devices Business (2020-2025)
7.19.5 Zhengkang Recent Development
7.20 Gerresheimer
7.20.1 Gerresheimer Company Details
7.20.2 Gerresheimer Business Overview
7.20.3 Gerresheimer Drug Delivery Devices Introduction
7.20.4 Gerresheimer Revenue in Drug Delivery Devices Business (2020-2025)
7.20.5 Gerresheimer Recent Development
7.21 COVIDIEN Medtronic
7.21.1 COVIDIEN Medtronic Company Details
7.21.2 COVIDIEN Medtronic Business Overview
7.21.3 COVIDIEN Medtronic Drug Delivery Devices Introduction
7.21.4 COVIDIEN Medtronic Revenue in Drug Delivery Devices Business (2020-2025)
7.21.5 COVIDIEN Medtronic Recent Development
7.22 Schott forma vitrum
7.22.1 Schott forma vitrum Company Details
7.22.2 Schott forma vitrum Business Overview
7.22.3 Schott forma vitrum Drug Delivery Devices Introduction
7.22.4 Schott forma vitrum Revenue in Drug Delivery Devices Business (2020-2025)
7.22.5 Schott forma vitrum Recent Development
7.23 Alkermes
7.23.1 Alkermes Company Details
7.23.2 Alkermes Business Overview
7.23.3 Alkermes Drug Delivery Devices Introduction
7.23.4 Alkermes Revenue in Drug Delivery Devices Business (2020-2025)
7.23.5 Alkermes Recent Development
7.24 Skyepharma
7.24.1 Skyepharma Company Details
7.24.2 Skyepharma Business Overview
7.24.3 Skyepharma Drug Delivery Devices Introduction
7.24.4 Skyepharma Revenue in Drug Delivery Devices Business (2020-2025)
7.24.5 Skyepharma Recent Development
8 Drug Delivery Devices Market Dynamics
8.1 Drug Delivery Devices Industry Trends
8.2 Drug Delivery Devices Market Drivers
8.3 Drug Delivery Devices Market Challenges
8.4 Drug Delivery Devices Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of TablesList of Tables
Table 1. Global Drug Delivery Devices Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Drug Delivery Devices Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Drug Delivery Devices Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Drug Delivery Devices Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Drug Delivery Devices Revenue Share by Region (2020-2025)
Table 6. Global Drug Delivery Devices Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Drug Delivery Devices Revenue Share Forecast by Region (2026-2031)
Table 8. Global Drug Delivery Devices Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Drug Delivery Devices Revenue Market Share by Type (2020-2025)
Table 10. Global Drug Delivery Devices Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Drug Delivery Devices Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Drug Delivery Devices Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Drug Delivery Devices Revenue Market Share by Application (2020-2025)
Table 15. Global Drug Delivery Devices Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Drug Delivery Devices Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Drug Delivery Devices Application
Table 18. Global Drug Delivery Devices Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Drug Delivery Devices Market Share by Players (2020-2025)
Table 20. Global Top Drug Delivery Devices Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Delivery Devices as of 2024)
Table 21. Ranking of Global Top Drug Delivery Devices Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Drug Delivery Devices Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Drug Delivery Devices, Headquarters and Area Served
Table 24. Global Key Players of Drug Delivery Devices, Product and Application
Table 25. Global Key Players of Drug Delivery Devices, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Drug Delivery Devices Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Drug Delivery Devices Revenue Market Share by Company (2020-2025)
Table 29. North America Drug Delivery Devices Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Drug Delivery Devices Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Drug Delivery Devices Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Drug Delivery Devices Revenue Market Share by Company (2020-2025)
Table 33. Europe Drug Delivery Devices Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Drug Delivery Devices Market Size by Application (2020-2025) & (US$ Million)
Table 35. Southeast Asia Drug Delivery Devices Revenue by Company (2020-2025) & (US$ Million)
Table 36. Southeast Asia Drug Delivery Devices Revenue Market Share by Company (2020-2025)
Table 37. Southeast Asia Drug Delivery Devices Market Size by Type (2020-2025) & (US$ Million)
Table 38. Southeast Asia Drug Delivery Devices Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Drug Delivery Devices Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Drug Delivery Devices Revenue Market Share by Company (2020-2025)
Table 41. Japan Drug Delivery Devices Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Drug Delivery Devices Market Size by Application (2020-2025) & (US$ Million)
Table 43. China Drug Delivery Devices Revenue by Company (2020-2025) & (US$ Million)
Table 44. China Drug Delivery Devices Revenue Market Share by Company (2020-2025)
Table 45. China Drug Delivery Devices Market Size by Type (2020-2025) & (US$ Million)
Table 46. China Drug Delivery Devices Market Size by Application (2020-2025) & (US$ Million)
Table 47. India Drug Delivery Devices Revenue by Company (2020-2025) & (US$ Million)
Table 48. India Drug Delivery Devices Revenue Market Share by Company (2020-2025)
Table 49. India Drug Delivery Devices Market Size by Type (2020-2025) & (US$ Million)
Table 50. India Drug Delivery Devices Market Size by Application (2020-2025) & (US$ Million)
Table 51. Cipla Company Details
Table 52. Cipla Business Overview
Table 53. Cipla Drug Delivery Devices Product
Table 54. Cipla Revenue in Drug Delivery Devices Business (2020-2025) & (US$ Million)
Table 55. Cipla Recent Development
Table 56. Baxter International Company Details
Table 57. Baxter International Business Overview
Table 58. Baxter International Drug Delivery Devices Product
Table 59. Baxter International Revenue in Drug Delivery Devices Business (2020-2025) & (US$ Million)
Table 60. Baxter International Recent Development
Table 61. Nipro Corporation Company Details
Table 62. Nipro Corporation Business Overview
Table 63. Nipro Corporation Drug Delivery Devices Product
Table 64. Nipro Corporation Revenue in Drug Delivery Devices Business (2020-2025) & (US$ Million)
Table 65. Nipro Corporation Recent Development
Table 66. Roche Company Details
Table 67. Roche Business Overview
Table 68. Roche Drug Delivery Devices Product
Table 69. Roche Revenue in Drug Delivery Devices Business (2020-2025) & (US$ Million)
Table 70. Roche Recent Development
Table 71. Boehringer Ingelheim Company Details
Table 72. Boehringer Ingelheim Business Overview
Table 73. Boehringer Ingelheim Drug Delivery Devices Product
Table 74. Boehringer Ingelheim Revenue in Drug Delivery Devices Business (2020-2025) & (US$ Million)
Table 75. Boehringer Ingelheim Recent Development
Table 76. Allergan Company Details
Table 77. Allergan Business Overview
Table 78. Allergan Drug Delivery Devices Product
Table 79. Allergan Revenue in Drug Delivery Devices Business (2020-2025) & (US$ Million)
Table 80. Allergan Recent Development
Table 81. 3M Company Details
Table 82. 3M Business Overview
Table 83. 3M Drug Delivery Devices Product
Table 84. 3M Revenue in Drug Delivery Devices Business (2020-2025) & (US$ Million)
Table 85. 3M Recent Development
Table 86. BD Company Details
Table 87. BD Business Overview
Table 88. BD Drug Delivery Devices Product
Table 89. BD Revenue in Drug Delivery Devices Business (2020-2025) & (US$ Million)
Table 90. BD Recent Development
Table 91. Catalent Company Details
Table 92. Catalent Business Overview
Table 93. Catalent Drug Delivery Devices Product
Table 94. Catalent Revenue in Drug Delivery Devices Business (2020-2025) & (US$ Million)
Table 95. Catalent Recent Development
Table 96. Valeant Pharmaceuticals Company Details
Table 97. Valeant Pharmaceuticals Business Overview
Table 98. Valeant Pharmaceuticals Drug Delivery Devices Product
Table 99. Valeant Pharmaceuticals Revenue in Drug Delivery Devices Business (2020-2025) & (US$ Million)
Table 100. Valeant Pharmaceuticals Recent Development
Table 101. Bayer AG Company Details
Table 102. Bayer AG Business Overview
Table 103. Bayer AG Drug Delivery Devices Product
Table 104. Bayer AG Revenue in Drug Delivery Devices Business (2020-2025) & (US$ Million)
Table 105. Bayer AG Recent Development
Table 106. Chiesi Company Details
Table 107. Chiesi Business Overview
Table 108. Chiesi Drug Delivery Devices Product
Table 109. Chiesi Revenue in Drug Delivery Devices Business (2020-2025) & (US$ Million)
Table 110. Chiesi Recent Development
Table 111. Phillips-Medisize Company Details
Table 112. Phillips-Medisize Business Overview
Table 113. Phillips-Medisize Drug Delivery Devices Product
Table 114. Phillips-Medisize Revenue in Drug Delivery Devices Business (2020-2025) & (US$ Million)
Table 115. Phillips-Medisize Recent Development
Table 116. Johnson & Johnson Company Details
Table 117. Johnson & Johnson Business Overview
Table 118. Johnson & Johnson Drug Delivery Devices Product
Table 119. Johnson & Johnson Revenue in Drug Delivery Devices Business (2020-2025) & (US$ Million)
Table 120. Johnson & Johnson Recent Development
Table 121. Shandong Weigao Company Details
Table 122. Shandong Weigao Business Overview
Table 123. Shandong Weigao Drug Delivery Devices Product
Table 124. Shandong Weigao Revenue in Drug Delivery Devices Business (2020-2025) & (US$ Million)
Table 125. Shandong Weigao Recent Development
Table 126. Pfizer Company Details
Table 127. Pfizer Business Overview
Table 128. Pfizer Drug Delivery Devices Product
Table 129. Pfizer Revenue in Drug Delivery Devices Business (2020-2025) & (US$ Million)
Table 130. Pfizer Recent Development
Table 131. B.Braun Company Details
Table 132. B.Braun Business Overview
Table 133. B.Braun Drug Delivery Devices Product
Table 134. B.Braun Revenue in Drug Delivery Devices Business (2020-2025) & (US$ Million)
Table 135. B.Braun Recent Development
Table 136. Novartis AG Company Details
Table 137. Novartis AG Business Overview
Table 138. Novartis AG Drug Delivery Devices Product
Table 139. Novartis AG Revenue in Drug Delivery Devices Business (2020-2025) & (US$ Million)
Table 140. Novartis AG Recent Development
Table 141. Zhengkang Company Details
Table 142. Zhengkang Business Overview
Table 143. Zhengkang Drug Delivery Devices Product
Table 144. Zhengkang Revenue in Drug Delivery Devices Business (2020-2025) & (US$ Million)
Table 145. Zhengkang Recent Development
Table 146. Gerresheimer Company Details
Table 147. Gerresheimer Business Overview
Table 148. Gerresheimer Drug Delivery Devices Product
Table 149. Gerresheimer Revenue in Drug Delivery Devices Business (2020-2025) & (US$ Million)
Table 150. Gerresheimer Recent Development
Table 151. COVIDIEN Medtronic Company Details
Table 152. COVIDIEN Medtronic Business Overview
Table 153. COVIDIEN Medtronic Drug Delivery Devices Product
Table 154. COVIDIEN Medtronic Revenue in Drug Delivery Devices Business (2020-2025) & (US$ Million)
Table 155. COVIDIEN Medtronic Recent Development
Table 156. Schott forma vitrum Company Details
Table 157. Schott forma vitrum Business Overview
Table 158. Schott forma vitrum Drug Delivery Devices Product
Table 159. Schott forma vitrum Revenue in Drug Delivery Devices Business (2020-2025) & (US$ Million)
Table 160. Schott forma vitrum Recent Development
Table 161. Alkermes Company Details
Table 162. Alkermes Business Overview
Table 163. Alkermes Drug Delivery Devices Product
Table 164. Alkermes Revenue in Drug Delivery Devices Business (2020-2025) & (US$ Million)
Table 165. Alkermes Recent Development
Table 166. Skyepharma Company Details
Table 167. Skyepharma Business Overview
Table 168. Skyepharma Drug Delivery Devices Product
Table 169. Skyepharma Revenue in Drug Delivery Devices Business (2020-2025) & (US$ Million)
Table 170. Skyepharma Recent Development
Table 171. Drug Delivery Devices Market Trends
Table 172. Drug Delivery Devices Market Drivers
Table 173. Drug Delivery Devices Market Challenges
Table 174. Drug Delivery Devices Market Restraints
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Drug Delivery Devices Product Picture
Figure 2. Global Drug Delivery Devices Market Share by Type: 2024 VS 2031
Figure 3. Injection Type Features
Figure 4. Mucosal Type Features
Figure 5. Implanted Type Features
Figure 6. Others Type Features
Figure 7. Global Drug Delivery Devices Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceutical Companies
Figure 9. Hospitals
Figure 10. Clinics
Figure 11. Other
Figure 12. Drug Delivery Devices Report Years Considered
Figure 13. Global Drug Delivery Devices Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Drug Delivery Devices Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Drug Delivery Devices Revenue Market Share by Region: 2020 VS 2024
Figure 16. North America Drug Delivery Devices Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Europe Drug Delivery Devices Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Southeast Asia Drug Delivery Devices Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Japan Drug Delivery Devices Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. China Drug Delivery Devices Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. India Drug Delivery Devices Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Australia Drug Delivery Devices Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. Global Drug Delivery Devices Market Share by Players in 2024
Figure 24. Global Top Drug Delivery Devices Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Delivery Devices as of 2024)
Figure 25. The Top 10 and 5 Players Market Share by Drug Delivery Devices Revenue in 2024
Figure 26. North America Drug Delivery Devices Market Share by Type (2020-2025)
Figure 27. North America Drug Delivery Devices Market Share by Application (2020-2025)
Figure 28. Europe Drug Delivery Devices Market Share by Type (2020-2025)
Figure 29. Europe Drug Delivery Devices Market Share by Application (2020-2025)
Figure 30. Southeast Asia Drug Delivery Devices Market Share by Type (2020-2025)
Figure 31. Southeast Asia Drug Delivery Devices Market Share by Application (2020-2025)
Figure 32. Japan Drug Delivery Devices Market Share by Type (2020-2025)
Figure 33. Japan Drug Delivery Devices Market Share by Application (2020-2025)
Figure 34. China Drug Delivery Devices Market Share by Type (2020-2025)
Figure 35. China Drug Delivery Devices Market Share by Application (2020-2025)
Figure 36. India Drug Delivery Devices Market Share by Type (2020-2025)
Figure 37. India Drug Delivery Devices Market Share by Application (2020-2025)
Figure 38. Cipla Revenue Growth Rate in Drug Delivery Devices Business (2020-2025)
Figure 39. Baxter International Revenue Growth Rate in Drug Delivery Devices Business (2020-2025)
Figure 40. Nipro Corporation Revenue Growth Rate in Drug Delivery Devices Business (2020-2025)
Figure 41. Roche Revenue Growth Rate in Drug Delivery Devices Business (2020-2025)
Figure 42. Boehringer Ingelheim Revenue Growth Rate in Drug Delivery Devices Business (2020-2025)
Figure 43. Allergan Revenue Growth Rate in Drug Delivery Devices Business (2020-2025)
Figure 44. 3M Revenue Growth Rate in Drug Delivery Devices Business (2020-2025)
Figure 45. BD Revenue Growth Rate in Drug Delivery Devices Business (2020-2025)
Figure 46. Catalent Revenue Growth Rate in Drug Delivery Devices Business (2020-2025)
Figure 47. Valeant Pharmaceuticals Revenue Growth Rate in Drug Delivery Devices Business (2020-2025)
Figure 48. Bayer AG Revenue Growth Rate in Drug Delivery Devices Business (2020-2025)
Figure 49. Chiesi Revenue Growth Rate in Drug Delivery Devices Business (2020-2025)
Figure 50. Phillips-Medisize Revenue Growth Rate in Drug Delivery Devices Business (2020-2025)
Figure 51. Johnson & Johnson Revenue Growth Rate in Drug Delivery Devices Business (2020-2025)
Figure 52. Shandong Weigao Revenue Growth Rate in Drug Delivery Devices Business (2020-2025)
Figure 53. Pfizer Revenue Growth Rate in Drug Delivery Devices Business (2020-2025)
Figure 54. B.Braun Revenue Growth Rate in Drug Delivery Devices Business (2020-2025)
Figure 55. Novartis AG Revenue Growth Rate in Drug Delivery Devices Business (2020-2025)
Figure 56. Zhengkang Revenue Growth Rate in Drug Delivery Devices Business (2020-2025)
Figure 57. Gerresheimer Revenue Growth Rate in Drug Delivery Devices Business (2020-2025)
Figure 58. COVIDIEN Medtronic Revenue Growth Rate in Drug Delivery Devices Business (2020-2025)
Figure 59. Schott forma vitrum Revenue Growth Rate in Drug Delivery Devices Business (2020-2025)
Figure 60. Alkermes Revenue Growth Rate in Drug Delivery Devices Business (2020-2025)
Figure 61. Skyepharma Revenue Growth Rate in Drug Delivery Devices Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
